Oncocytic change in pleomorphic adenoma: molecular evidence in support of an origin in neoplastic cells
暂无分享,去创建一个
A. Ashworth | J. Reis-Filho | Chris Jones | K. Fenwick | A. Mackay | T. Dexter | K. Savage | M. Lambros | S. Di Palma | M. Iravani
[1] A. Ashworth,et al. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity , 2005, The Journal of pathology.
[2] G. Stenman. Fusion oncogenes and tumor type specificity--insights from salivary gland tumors. , 2005, Seminars in cancer biology.
[3] I. Leivo,et al. Non‐invasive (intracapsular) carcinoma ex pleomorphic adenoma: recognition of focal carcinoma by HER‐2/neu and MIB1 immunohistochemistry , 2005, Histopathology.
[4] E. Fonseca,et al. Hürthle (Oncocytic) Cell Tumors of Thyroid: Etiopathogenesis, Diagnosis and Clinical Significance , 2005, International journal of surgical pathology.
[5] Emmanuel Barillot,et al. Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..
[6] P. Raychaudhuri,et al. Cul4A Physically Associates with MDM2 and Participates in the Proteolysis of p53 , 2004, Cancer Research.
[7] V. Trovisco,et al. BRAF mutations are associated with some histological types of papillary thyroid carcinoma , 2004, The Journal of pathology.
[8] P. Raychaudhuri,et al. Cul 4 A Physically Associates with MDM 2 and Participates in the Proteolysis of p 53 , 2004 .
[9] Guillermina Lozano,et al. MDM2, an introduction. , 2003, Molecular cancer research : MCR.
[10] Masakazu Ueda,et al. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas , 2002, Hepatology.
[11] M. Stanley. Selected Problems in Fine Needle Aspiration of Head and Neck Masses , 2002, Modern Pathology.
[12] J. Bullerdiek,et al. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. , 2002, The American journal of pathology.
[13] F. Barr,et al. Molecular Pathogenesis of Rhabdomyosarcoma , 2002, Cancer biology & therapy.
[14] H. Tanke,et al. Characterization of chromosome aberrations in salivary gland tumors by FISH, including multicolor COBRA‐FISH , 2001, Genes, chromosomes & cancer.
[15] M. Sobrinho-Simões,et al. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance , 2000, Virchows Archiv.
[16] D. Gisselsson,et al. Locus‐specific multifluor FISH analysis allows physical characterization of complex chromosome abnormalities in neoplasia , 2000, Genes, chromosomes & cancer.
[17] M. Lingen,et al. Differentiation and the cytomorphology of salivary gland tumors with specific reference to oncocytic metaplasia. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[18] Y. Takeda. An immunohistochemical study of bizarre neoplastic cells in pleomorphic adenoma: Its cytological nature and proliferative activity , 1999, Pathology international.
[19] P. D. Dal Cin,et al. HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors. , 1999, Advances in anatomic pathology.
[20] P. Rogalla,et al. Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements. , 1999, Cancer genetics and cytogenetics.
[21] I. Leivo,et al. Oncocytic myoepithelioma and pleomorphic adenoma of the salivary glands , 1999, Virchows Archiv.
[22] O. Nappi,et al. Oxyphilic proliferations of the respiratory tract and paranasal sinuses. , 1999, Seminars in diagnostic pathology.
[23] M. Papotti,et al. Oncocytic and oncocytoid tumors of the exocrine pancreas, liver, and gastrointestinal tract. , 1999, Seminars in diagnostic pathology.
[24] Z. Baloch,et al. Oncocytic Lesions of the Neuroendocrine System , 1999, Seminars in diagnostic pathology.
[25] A. Huvos,et al. Oncocytic and oncocytoid tumors of the salivary glands. , 1999, Seminars in diagnostic pathology.
[26] P. Rao,et al. Nonsyntenic amplification of MYC with CDK4 and MDM2 in a malignant mixed tumor of salivary gland. , 1998, Cancer genetics and cytogenetics.
[27] W. Kuo,et al. The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers. , 1998, Cancer research.
[28] W. V. D. Van de Ven,et al. Molecular characterization of a complex chromosomal rearrangement in a pleomorphic salivary gland adenoma involving the 3'-UTR of HMGIC. , 1997, Cancer genetics and cytogenetics.
[29] W. V. D. Van de Ven,et al. In a Pleomorphic Adenoma of the Parotid Gland Fhit and Hmgic Expression of Reciprocal Hybrid Transcripts of Updated Version Citing Articles E-mail Alerts Expression of Reciprocal Hybrid Transcripts of Hmgic and Fhit in a Pleomorphic Adenoma of the Parotid Gland' , 2013 .
[30] Auclair Pl,et al. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. , 1996 .
[31] G. Ellis,et al. Atypical features in salivary gland mixed tumors: their relationship to malignant transformation. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[32] V. Collins. Gene amplification in human gliomas , 1995, Glia.
[33] N. Stylopoulos,et al. Oncocytic differentiation in salivary gland tumours , 1995, The Journal of Laryngology & Otology.
[34] Gnepp Dr. Malignant mixed tumors of the salivary glands: a review. , 1993 .
[35] D. Gnepp. Malignant mixed tumors of the salivary glands: a review. , 1993, Pathology annual.
[36] J. Eveson,et al. Oncocytic adenomas and oncocytic hyperplasia of salivary glands: a clinicopathological study of 26 cases , 1990, Histopathology.
[37] C. Micheau,et al. Histology of the major salivary glands. , 1989, The American journal of surgical pathology.
[38] Butler. ROYAL SURREY COUNTY HOSPITAL. , 1876 .